Development, validation and stability study of pediatric atenolol syrup

Pharmazie

Volumn 62, Issue 7, 2007, Pages 519-521

  Foppa, Talize ^a   Murakami, F S ^a   Silva, M A S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL;

ACCURACY; ARTICLE; CHROMATOGRAPHY; DRUG DECOMPOSITION; DRUG DEGRADATION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG SOLUTION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REPRODUCIBILITY; SYRUP; TEMPERATURE DEPENDENCE; THERMOSTABILITY; VALIDATION PROCESS;

ADRENERGIC BETA-ANTAGONISTS; ATENOLOL; CHEMISTRY, PHARMACEUTICAL; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HUMANS; INDICATORS AND REAGENTS; KINETICS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SOLUTIONS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 34447514365     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.7.6179     Document Type: Article

References (7)

1. Chiap B, Miralles BA, Ceccato, PH, Crommen J (2000) Automated liquid chromatographic determination of atenolol in plasma using dialysis and trace enrichment on a cation-exchange precolumn for sample handling. J Chromatogr B 739: 205-217.
2. Garner SS, Wiest, DB, Reynolds Jr (1994) Stability of atenolol in an extemporaneously compounded oral liquid. Am J Hosp Pharm 51: 508-511.
3. ICH-International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human use: Q2B-validation of Analytical procedures: methodology 2000.
4. Nahata MC (1999) Pediatric drug formulations: Challenges and potential solutions. Ann Pharmacother 33: 247-249.
5. Nahata CM (2000) Need for extemporaneous formulations in pediatric patients. Curr Pract Compound Inform Pharm 8: 235-239.
6. Schirm E, Tobi H, Lolkje TWJ (2003) Risk factors for unlicensed and off-label use in children outside the hospital. Pediatrics 111: 291-295.
7. Standing FJ, Tuleu C (2005) Pediatric formulations - getting to the heart of the problem. Int J Pharm 300: 56-66.